Maraviroc bulk supplier for pharma manufacturers

Maraviroc Suppliers & Bulk Manufacturers

Available Forms: Tablets / Oral solution

Available Strengths: 150 mg, 300 mg, 20 mg

Reference Brands: Selzentry (USA), Celsentri (EU)

Category: Anti Viral

Maraviroc is an antiretroviral medication used in the treatment of HIV-1 infection. It works by blocking the CCR5 co-receptor on human cells, preventing the virus from entering and infecting immune cells. Maraviroc is used in combination with other antiretroviral agents for effective HIV management. Maraviroc is available in Tablets / Oral solution and strengths such as 150 mg, 300 mg, 20 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Maraviroc is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Maraviroc can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Maraviroc is used to treat HIV-1 infection in adults and children aged two years and older who are CCR5-tropic, typically in combination with other antiretroviral medications.

Maraviroc is a CCR5 receptor antagonist that blocks the CCR5 co-receptor on human CD4+ cells, preventing the HIV virus from entering and infecting these cells.

The trade name is Selzentry (USA) and Celsentri (EU/UK).

It is manufactured by Pfizer Inc.

The generic name is maraviroc.

Brand names include Selzentry and Celsentri.

Maraviroc is produced under Good Manufacturing Practice conditions in Pfizer’s pharmaceutical manufacturing facilities.

Yes, Maraviroc is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Maraviroc is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Maribavir

Strength:
200 mg

Form: Tablets

Reference Brands: Livtencity (USA/EU)

View Details
Nifurtimox

Strength:
30 mg, 120 mg

Form: Tablet

Reference Brands: Lampit (USA)

View Details
Raltegravir

Strength:
100mg, 400 mg, 600mg

Form: Tablets

Reference Brands: Isentress (USA/EU)

View Details
Enfuvirtide Acetate

Strength:
90 mg/vial

Form: Injection

Reference Brands: Fuzeon (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.